Jilin Aodong Pharmaceutical Group (000623.SZ): has cumulatively repurchased 1.71% of its shares.

On February 5, Glonghui reported that Jilin Aodong Pharmaceutical Group (000623.SZ) announced that as of January 31, 2025, the company had cumulatively repurchased 20,443,900 shares of its stock through a dedicated securities account via centralized bidding Trade, accounting for 1.71% of the total share capital of 1,195,895,387 shares as of January 31, 2025. The highest Fill Price was 19.21 yuan per share, the lowest Fill Price was 15.80 yuan per share, and the total amount paid was 0.369 billion yuan (excluding transaction fees).

Gelonghui FinanceFeb 5 17:19

Express News | Jilin Aodong Pharmaceutical Group: The holding subsidiary has obtained the registration certificate for Lenvatinib Mesylate Capsules.

BreakingsJan 13 16:27

Jilin Aodong Pharmaceutical Group (000623.SZ): Currently, the production of Oseltamivir phosphate capsules is normal and can meet the medication needs of the general public.

On January 7th, GiLonghui reported that Jilin Aodong Pharmaceutical Group (000623.SZ) stated on the investor interaction platform that recently, with the high incidence of influenza, the company produces Oseltamivir phosphate capsules in three specifications of 45mg, 30mg, and 75mg, which are used for the treatment of Type A and Type B influenza in adults and children aged 1 year and older, as well as for the prevention of Type A and Type B influenza in adults and adolescents aged 13 and above. It is a preferred medication Against Influenza. Currently, the company's production of Oseltamivir phosphate capsules is normal and can meet the medication needs of the general public.

Gelonghui FinanceJan 7 18:00

Express News | Jilin Aodong Pharmaceutical Group: The product Xuefu Zhuyu Oral Liquid is proposed to be selected for the national Chinese Patent Medicine procurement alliance centralized volume-based procurement.

BreakingsJan 3 17:07

Jilin Aodong Pharmaceutical Group (000623.SZ) held subsidiary Yanbian Pharmaceutical has obtained several Traditional Chinese Medicine formula granule上市备案凭证.

Jilin Aodong Pharmaceutical Group (000623.SZ) announced that its holding subsidiary Jilin Aodong Yanbian Pharmaceutical Co., Ltd. (abbreviated...)

Zhitong FinanceDec 30, 2024 16:51

jilin aodong pharmaceutical group (000623.SZ): Subsidiary obtains pharmaceutical registration certificate for amlodipine besylate tablets.

Gelonghui, December 3 - Jilin Aodong (000623.SZ) announced that recently, Jilin Aodong Pharmaceutical Group Co., Ltd.'s controlling subsidiary, Jilin Aodong Pharmaceutical Group Yanji Co., Ltd., received the "Drug Registration Certificate" from the National Medical Products Administration for the specification of Amlodipine Besylate Tablets: 5mg.

Gelonghui FinanceDec 3, 2024 17:20